NEW YORK (
CHANGE IN RATINGS
Arcos Dorados Holdings
(ARCO) was downgraded to sell at TheStreet Ratings.
Bona Film Group
(BONA) was downgraded to sell at TheStreet Ratings.
Charles River Laboratories
(CRL - Get Report) was downgraded at Goldman Sachs to sell from neutral. $38 price target. RMS softness adds to preclinical worries, Goldman said.
(CVLT - Get Report)
was upgraded at Pacific Crest to outperform. $92 price target. Company is gaining market share and should benefit from a new product cycle, Pacific Crest said.
was initiated with a buy rating at Needham. $20 price target. Investor sentiment appears to have bottomed, Needham said.
was downgraded at Stifel Nicolaus to hold from buy. Tank car order rates are not sustainable, Stifel Nicolaus said.
(LNKD - Get Report)
was initiated with an outperform rating at Pacific Crest. $215 price target. Company has clear monetization and scarcity benefits, Pacific Crest said.
was upgraded at Stifel Nicolaus to buy from hold. $29 price target. Expect an NAV increase, Stifel Nicolaus said.
People's United Financial
was upgraded at J.P. Morgan to overweight from neutral. 15%-plus upside to 2014 consensus and best entry point in two years, J.P. Morgan said.
(Q - Get Report)
was initiated at Morgan Stanley with an overweight rating and a $51 price target. The company stands to benefit from being the leader in the high-growth biopharmaceutical R&D outsourcing market.
Quintiles Transnational was initiated at Goldman Sachs with a neutral rating and a $44 price target. The company's global scale and scientific expertise will benefit from the growth in the biopharmaceutical industry, Goldman said.
Quintiles Transnational was initiated with a neutral rating at Robert Baird. $46 price target. Company has low, decelerating growth, Baird said.
was downgraded at Keybanc to hold from buy. Valuation call, said Keybanc.
was initiated with a hold rating at Canaccord and a $22 price target. Although TMUS is an attractive takeover candidate, absent such an event the stock appears fully valued, Canaccord said.
(WETF - Get Report)
was downgraded at Citigroup to neutral. Much of the upside is already priced in to the stock, Citigroup said. Price target was reduced to $13.50.